GetTopicDetailResponse(id=57781150e10e, topicName=第三代ALK抑制劑, introduction=, content=第三代ALK抑制劑, image=null, comments=0, allHits=348, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Fri May 31 22:24:39 CST 2024, time=2024-05-31, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=437373, tagList=[TagDto(tagId=437373, tagName=第三代ALK抑制劑)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2207707, encodeId=4d84220e707ec, content=<a href='/topic/show?id=57781150e10e' target=_blank style='color:#2F92EE;'>#第三代ALK抑制劑#</a>, objectTitle=2024 ASCO公布第三代ALK抑制劑長期隨訪數(shù)據(jù)，患者中位無進(jìn)展生存期突破五年 , objectType=article, longId=827839, objectId=389582e8397b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240530/1717052859978_5579292.png, objectUrl=/article/show_article.do?id=389582e8397b, replyNumber=0, likeNumber=76, createdTime=2024-05-31, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=389582e8397b, moduleTitle=2024 ASCO公布第三代ALK抑制劑長期隨訪數(shù)據(jù)，患者中位無進(jìn)展生存期突破五年 , moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=389582e8397b)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-05-31發(fā)表于上海
